Molecular structure of Delanzomib, free base
Delanzomib, free base (CAS 847499-27-8)
Alternate Names:
[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid
Application:
Delanzomib, free base is a proteasome inhibitor
CAS Number:
847499-27-8
Molecular Weight:
413.28
Molecular Formula:
C21H28BN3O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Delanzomib, free base is a proteasome inhibitor. Delanzomib inhibits chymotrypsin-like proteasome activity with an IC50 of 3.8 nM. Delanzomib blocks the growth of representative human solid and hematological tumor cell lines with IC50 values of
Inhibitor of:
20S Proteasome α2, 20S Proteasome α3, 20S Proteasome α5, 20S Proteasome α7, 20S Proteasome α8, 20S Proteasome β1, 20S Proteasome β2, 20S Proteasome β5, 26S Proteasome p42C, 26S Proteasome p48A, 26S Proteasome p50, 26S Proteasome p54, 26S Proteasome p58, Angiogenesis, ASB-2, AV320801, Cdc23, chaperonin containing TCP1 ring complex (CCT), CSN7b, Dda1, Derlin-1, EG382106, EG382156, Glomulin, Herc1, Ig κ light chain, Josephin-2, KLHL33, LONRF3, NEURL4, NOB1P, PA, POT1, Proteassemblin, PSMB11, PSMB4, PSMB6, PSMC1, PSMC2, PSMC4, PSMC6, PSMD12, PSMD7, PSMD8, PSME proteasome activator subunits (PA28), Rad23, RNF121, RNF130, RNF152, RNF166, RNF180, RNF187, RNF219, Rpn11, SHARPIN (SHANK associated RH domain interactor), SHFM3, Slimb, SUG1, TRIM23, TRIM31, TRIM40, TRIM45, UBE3B, UBXD7, USP21, V1RH5, WDR20a, ZFAND1, ZNF114, and ZNF121.Activator of:
20S Proteasome α6, 26S Proteasome α, A1Up, ADRM1, CRLF3, FBXO35, Neuralized-2, Ninein, PI31, POH1, PSMD2, PSMD8, Rad23A, and UCH-L3.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Delanzomib, free base, 5 mg | sc-396774 | 5 mg | $160.00 | |||
Delanzomib, free base, 10 mg | sc-396774A | 10 mg | $300.00 |